neuregulin-1 modulators (deCODE/Roche)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameneuregulin-1 modulators (deCODE/Roche)
Drug Alias Nameantipsychotic (deCODE/Roche)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-4 modulatorsNeuregulin-1 modulators
TargetsNeuregulin-1Receptor protein-tyrosine kinase erbB-4
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandIceland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDecode Genetics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche LtdDecode Genetics
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A